Browse All Providers

Find a Provider Near You

Find A Provider
Browse All Specialties

Learn more about a specialty

Find A Specialty
Accepted Insurance

Check to see if your insurance plan is accepted by CU Medicine Clinics.

Check for Insurance

Practice Locations

UCHealth Neurosciences Center - Anschutz Medical Campus
1635 Aurora Ct 4th Floor, Aurora, CO 80045

720-848-2080

Denise Damek, MD

Neurology

Board Certified

Schedule Appointment

  • Gender

    Female

  • Languages

    English

  • Department

    Professor, Neurology

  • Specialty

    Neurology, Neuro-Oncology

  • Primary Clinic Phone

    (720) 848-0300

  • Hospital Affiliations

    University of Colorado Hospital
Print Share

Referring Provider Info

Locations

Practice Locations

University of Colorado Cancer Center
CU Anschutz Medical Campus
1665 Aurora Ct, Aurora, CO 80045

720-848-0300

UCHealth Neurosciences Center - Anschutz Medical Campus
1635 Aurora Ct 4th Floor, Aurora, CO 80045

720-848-2080

UCHealth Brain and Spine Tumor Multidisciplinary Clinic - Anschutz Medical Campus
1665 Aurora Court, Anschutz Cancer Pavilion, 2nd Floor, Suite 2004 Aurora, CO 80045

720-848-0300

Provider Expertise

Specialties

  • Neurology ( 1998 )
  • Neuro-Oncology

Conditions & Treatments

  • Cancers

  • Brain and Nervous System

    Brain Tumors, Spine Diseases and Conditions

Education & Training

Medical Schools

MD, University of Texas Medical School at Houston (1992)


Undergraduate Schools

BS, University of Texas–Austin (TX) (1988)


Internships

College of Medicine, Mayo Clinic (Rochester) Program (1993)


Residency Program

College of Medicine, Mayo Clinic (Rochester) Program (1996)


Fellowships

Massachusetts General Hospital Program (1998)

Professional Memberships

American Academy of Neurology, Member


American Medical Association, Member


Society for Neuro-Oncology, Member


Research & Grants

Grants

A Randomized Phase 3 Open Label Study of Nivolumab versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Adult Subjects with Recurrent Glioblastoma (2014)

Immunocellular Therapeutics Ltd. ICT-107-301. A phase III randomized double-blind, controlled study of ICT-107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy (2015)

Chart Review Study of Patients who Received IRESSA as Part of a Clinical Access Program (ICAP) in the United States (2015)

ABT-414 alone or ABT-414 plus temozolomide for recurrent glioblastoma: a randomized phase II study of the EORTC Brain Tumor Group (2016)

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined with Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma (2016)


information for referring providers

Referral Contact Phone

(720) 848-0300

Referral Contact Fax

720-848-0360

Clinical Interests for Referring Providers

Neuro-oncology including: Diagnosis and Treatment of Primary and Metastic Tumors of Brain and Spinal Cord, Paraneoplastic Disorders and Other Neurologic Complications of Systemic Cancer, CNS Lymphoma, Radiation Necrosis involving Nervous System